SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Advanced Viral Research CP (ADVR)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mark Chavez who wrote (1885)12/17/1996 8:33:00 AM
From: Oak Tree   of 2281
 
Mark, you're right. Old news on ADVR gets recirculated as new news regularly. This stock appears to be an individual investor type hype stock at present. Institutions have stayed away so far. Some call it Ardvark. As an example, nearly a year ago there was a surge in ADVR based on a presentation at a meeting. The paper from that meeting came out about 6 mo later-- same news in print as was in the original abstract-- there was nevertheless a new 60% spike in price. After the rehash of news occurs, the price returns to a more usual trading range. That is it falls from 80 to 40 cents! This stock is going to be a rocky ride for a couple of years. Hope I'm in big when it finally sky-rockets.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext